¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"involved field radiotherapy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® visual field test ÇÑ±Û ½Ã¾ß°Ë»ç
¼³¸í   
  ´«À» ÇѰ÷¿¡ °íÁ¤½ÃŲ Ã¤, °üÂûÇÒ ¼ö Àִ ÁÖº¯°ø°£À» ½Ã¾ß¶ó ÇÑ´Ù. ½Ã¾ß¸¦ °Ë»çÇϴ °¡Àå °£´ÜÇÑ ¹æ¹ýÀº ´ë¸é°Ë»ç(confronting test)ÀÌ´Ù. À̰ÍÀº Çǰ˻çÀÚÀÇ ´«À» °Ë»çÀÚÀÇ ´«¿¡ ¸ÂÃ߾¸µµ·Ï ÇÏ¿© ´«À» °íÁ¤½ÃŲä, °Ë»çÀÚ°¡ ¼Õ°¡¶ô³¡À» À§ÂÊ, ¾Æ·¡ÂÊ, ¿ÞÂÊ, ¿À¸¥ÂÊ, ±×¸®°í ºñ½ºµëÈ÷ °æ»çÁø °÷ µîÀ¸·Î ¿Å°Üº¸¾Æ Çǰ˻çÀÚ°¡ °üÂûÇÒ ¼ö ÀÖ´ÂÁö ¿©ºÎ¸¦ Á¤Çϴ °Ë»ç¹ýÀÌ´Ù. À̺¸´Ù Á¤È®ÇÑ °Ë»ç¹ýÀº ÀÚµ¿½Ä ÄÄÇ»Åͽþ߰˻ç¹ýÀÌ ÀÖ´Ù. ´ë°³, ´«ÀÚüÀÇ ÀÌ»óÀÌ À־ ½Ã¾ß°Ë»ç¿¡¼­ ÀÌ»óÀÌ ³ª¿ÀÁö¸¸, À̿ܠ³úÀÇ ÀÌ»óÀ¸·Î ½Ã°¢ÀÇ Çü¼º°æ·Î¿¡ ÀÌ»óÀÌ À־ ¿ª½Ã ÀÌ»ó¼Ò°ßÀ» º¸ÀδÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • continuous hyperfractionated accelerated radiotherapy
    ¿¬¼Ó°úºÐÇÒ°¡¼Ó¹æ»ç¼±Ä¡·á
  • endoluminal radiotherapy
    °ü³»¹æ»ç¼±Ä¡·á
  • hyperfractionated radiotherapy
    °ú´ÙºÐÇÒ¹æ»ç¼±Ä¡·á
  • high dose rate intraluminal radiotherapy
    °í¼±·®·ü°ü³»¹æ»ç¼±Ä¡·á
  • inverse radiotherapy
    µµÄ¡¹æ»ç¼±Ä¡·á
  • mantle radiotherapy
    ¸ÇƲ¹æ»ç¼±Ä¡·á
  • radiotherapy
    ¹æ»ç¼±Ä¡·á, ¹æ»ç¼±¿ä¹ý
  • auditory field
    û°¢¹üÀ§, û¿ª
  • altitudinal visual field defect
    ¼öÆò½Ã¾ß°á¼Õ
  • abutted field
    ÀÎÁ¢Á¶»ç¸é, Á¢ÃËÁ¶»ç¸é
  • B1 field gradient
    ȸÀüÀÚÀå±â¿ï±â
  • binocular field
    ¾ç¾È½Ã¾ß, µÎ´«½Ã¾ß
  • boost field
    Á¶»ç¿µ¿ª, Á¶»ç¸é
  • complex receptive field
    º¹ÇÕ¼ö¿ë¾ß
  • comprehensive field irradiation
    ±¤¹üÀ§Á¶»ç
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • radiotherapy
    ¹æ»ç¼±Ä¡·á
  • visual field defect
    ½Ã¾ß°á¼Õ
  • field
    1. ºÐ¾ß, ¿µ¿ª, ¹üÀ§, 2. ºÎÀ§, 3. ½Ã¾ß, 4. Àü±âÀå
  • boost field
    Á¶»ç¿µ¿ª, Á¶»ç¸é
  • electropmagnetic field
    ÀüÀÚ±âÀå
  • irradiation field
    Á¶»ç¿µ¿ª
  • radiation field
    ¹æ»ç¼±Á¶»ç¿µ¿ª
  • sound field
    À½¿ª
  • static magnetic field
    Á¤ÀÚ±âÀå
  • visual field
    ½Ã¾ß
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • continuous hyperfractionated accelerated radiotherapy
    ¿¬¼Ó°úºÐÇÒ°¡¼Ó¹æ»ç¼±Ä¡·á
  • endoluminal radiotherapy
    °ü³»¹æ»ç¼±Ä¡·á
  • high dose rate intraluminal radiotherapy
    °í¼±·®À²°ü³»¹æ»ç¼±Ä¡·á
  • hyperfractionated radiotherapy
    °ú´ÙºÐÇÒ¹æ»ç¼±Ä¡·á
  • inverse radiotherapy
    µµÄ¡¹æ»ç¼±Ä¡·á
  • mantle radiotherapy
    ¸ÇƲ¹æ»ç¼±Ä¡·á
  • radiotherapy
    ¹æ»ç¼±Ä¡·á
  • abutted field
    ÀÎÁ¢Á¶»ç¸é, Á¢ÃËÁ¶»ç¸é
  • altitudinal visual field defect
    ¼öÆò½Ã¾ß°á¼Õ
  • auditory field
    û°¢¹üÀ§, û¿ª
  • geometric field distortion artifact
    ±âÇÏÇÐÀûÀÚÀå¿Ö°îÀΰø¹°
  • B1 field gradient
    ȸÀüÀÚÀå±â¿ï±â
  • binocular field
    ¾ç¾È½Ã¾ß, µÎ´«½Ã¾ß
  • boost field
    Á¶»ç¿µ¿ª, Á¶»ç¸é
  • field block
    ºÎÀ§Â÷´Ü¸¶Ãë
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • high dose rate intraluminal radiotherapy
    °í¼±·®À² °ü³»¹æ»ç¼±Ä¡·á
  • radiotherapy
    ¹æ»ç¼± Ä¡·á
  • radiotherapy
    ¹æ»ç¼±Ä¡·á
  • B1 field gradient
    ȸÀü ÀÚÀå Àڱ⠰æ»ç
  • FFE, fast field echo
    ±Þ¼Ó ÀÚÀå ¿¡ÄÚ
  • FOV(field of view)
    ¿µ»ó ¿µ¿ª, ¿µ»ó ¹üÀ§
  • Goldman constant-field equation
    °ñµå¸¸ Á¤Àü·ù(ïÒï³×µ) ½Ä
  • abutted field
    ÀÎÁ¢Á¶»ç¸é, -¿µ¿ª, Á¢ÃËÁ¶»ç¸é
  • altitudinal visual field defect
    ¼öÆò½Ã¾ß°á¼Õ
  • fringe field
    ÁÖº¯ ¾ß
  • fringe magnetic field strength
    ÁÖº¯ ÀÚÀå ¼¼±â
  • frontal adversive field
    ÀüµÎ¿±´ëÃø¾ß(¡­Óßö´å¯), Àü¿îµ¿¿ª(îñê¡ÔÑæ´).
  • geometric field distortion artifact
    ±âÇÏÇÐÀû ÀÚÀå ¿Ö°î Àΰø¹°
  • geometric field separtion
    ±âÇÏÇÐÀûÁ¶»ç¿µ¿ªºÐ¸®
  • geometrical field
    ±âÇÏÇÐÀûÁ¶»ç¿µ¿ª
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • endoluminal radiotherapy
    °ü³» ¹æ»ç¼± Ä¡·á
  • high dose rate intraluminal radiotherapy
    °í¼±·®À² °ü³»¹æ»ç¼±Ä¡·á
  • inverse radiotherapy
    µµÄ¡ ¹æ»ç¼± Ä¡·á
  • mantle radiotherapy
    ¸ÇƲ¹æ»ç¼±Ä¡·á
  • radiotherapy
    ¹æ»ç¼±Ä¡·á
  • radiotherapy
    ¹æ»ç¼± Ä¡·á
  • field within a field technique
    Áߺ¹Á¶»ç¿µ¿ª¹ý
  • abutted field
    ÀÎÁ¢Á¶»ç¸é, -¿µ¿ª, Á¢ÃËÁ¶»ç¸é
  • altitudinal visual field defect
    ¼öÆò½Ã¾ß°á¼Õ
  • auditory field
    û¿ª, û¾ß
  • binocular field
    ¾ç¾È½Ã¾ß
  • blue-field entopic phenomenon
    û»ö½Ã¾ß³»½ÃÇö»ó
  • boost field
    Ãß°¡Á¶»ç¿µ¿ª, Ãß°¡Á¶»ç¸é
  • bright field microscopy
    ¸í½Ã¾ß Çö¹Ì°æ¹ý
  • complex receptive field
    º¹ÇÕ¼ö¿ë¾ß(¡­áôé»å¯).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Nail field
    ¹ßÅ鱸¿ª
    [¿¾ ¿ë¾î] Á¶¾ß
  • Nail field
    ¼ÕÅ鱸¿ª
    [¿¾ ¿ë¾î] Á¶¾ß
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • radiotherapy
    ¹æ»ç¼±Ä¡·á (Û¯ÞÒàÊö½Öû)
  • centrifugal field
    ¿ø½É·Â Àå(êÀãýÕôíÞ)
  • crystal field splitting
    °áÁ¤ ÀåºÐÇÒ(Ì¿ïÜíÞÝÂùÜ)
  • crystal field theory
    °áÁ¤ Àå·Ð(Ì¿ïÜíÞÖå)
  • electric field
    ÀüÀå(ï³íÞ) °ãÃþ(öµ)
  • field desorption mass spectrometry
    ÀåÅ»Âø Áú·®ºÐ±¤ÃøÁ¤¹ý (íÞ÷­ó·òõÕáÝÂÎÃö´ïÒÛö)
  • field effect
    ÀåÈ¿°ú(íÞüùÍý)
  • field flow fractionation
    Àå(íÞ)È帧 ºÐȹ¹ý(ÝÂüñÛö)
  • field inversion gel electrophoresis
    ÀåÀüµµ(íÞï´Óî) Á© Àü±â¿µµ¿(ï³Ñ¨ç¶ÔÑ)
  • field ionization mass spectrometry
    Àå(íÞ) ÀÌ¿ÂÈ­(ûù) Áú·®ºÐ±¤ÃøÁ¤¹ý(òõÕáÝÂÎÃö´ïÒÛö)
  • field ion microscope
    Àå(íÞ) À̿ Çö¹Ì°æ(úéÚ°Ìð)
  • ligand field theory
    ¸®°£µåÀå(íÞ) ÀÌ·Ð(ìµÖå)
  • linear electric field effect
    ¼±Çü Àü±âÀåÈ¿°ú(àÊû¡ï³Ñ¨íÞüùÍý)
  • magnetic field
    ÀÚÀå(í¸íÞ)
  • pulsed-field gel electrophoresis
    ÆÞ½ºÀå(íÞ) Á© Àü±â¿µµ¿(ï³Ñ¨ç¶ÔÑ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • intraoperative radiotherapy
    ¼ö¼úÁß¹æ»ç¼±Ä¡·á
  • radiotherapy
    ¹æ»ç¼±¿ä¹ý, ¹æ»ç¼±Ä¡·á
  • B1 field gradient
    ȸÀüÀÚÀå°æ»ç
  • constant field gradient spin echo method
    °íÁ¤°æ»çÀ彺ÇÉ¿¡ÄÚ¹ý
  • demagnetizing field
    ¹ÝÀÚÀå
  • electromagnetic field
    ÀüÀÚ(±â)Àå
  • far field
    ¿ø°Å¸®±¸¿ª
  • fast field echo [=FFE]
    ±Þ¼ÓÀÚÀå¿¡ÄÚ
  • FFE [=fast field echo]
    ±Þ¼ÓÀÚÀå¿¡ÄÚ
  • field
    ¾ß, ¿µ¿ª, Çʵå, Ç׸ñ
  • field echo
    ÀÚÀå¿¡ÄÚ
  • field gradient
    ÀÚÀå°æ»ç
  • field inhomogeneity
    ÀÚÀåºÒ±ÕÀÏ(¼º)
  • field of view [=FOV]
    ¿µ»ó¿µ¿ª, ¿µ»ó¹üÀ§
  • field profile
    ÀÚÀåÃø¸é»ó
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
IF idiopathic fibroplasia; idiopathic flushing; immersion foot; immunofluorescence; indirect fluorescen...
IFRT involved field radiotherapy
EF ectopic focus; edema factor; ejection fraction; elastic fibril; electric field; elongation factor; e...
AS-SCORE age, stage of disease, physiological system involved, complications, response to therapy
che a gene involved in chemotaxis
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
IF Involved field
I involved
E-field Electric field
CHART Continuous Hyperfractionated Accelerated Radiotherapy
ERT External Radiotherapy
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • intraoperative radiotherapy
    ¼ö¼ú Áß ¹æ»ç¼± Ä¡·á
  • radiotherapy
    ¹æ»ç¼± ¿ä¹ý, ¹æ»ç¼± Ä¡·á
    1. Àü¸® ¹æ»ç¼±À» ÀÌ¿ëÇÏ¿© Áúº´À» Ä¡·áÇÏ´Â ¹æ¹ý. 2. Á¾·¡¿¡´Â X¼± ¿ä¹ý ¹× ¶óµã ¿ä¹ýÀ» ¸»ÇÑ °ÍÀ̾úÀ¸³ª ÃÖ±Ù¿¡ ¿Í¼­ Ãʰí¾Ð ¹æ»ç¼±, Áß¼ºÀÚ¼±, Àΰø ¹æ»ç¼º µ¿À§¿ø¼Ò µîÀ» Æ÷ÇÔÇÏ´Â ¹æ»ç¼± Ä¡·á¸¦ ÀÏÄ´ ¸». Àû´çÇÑ ¾çÀÇ ¹æ»ç¼±À» ȯºÎ¿¡ Á¶»çÇÔÀ¸·Î½á º´¼Ò¸¦ Ä¡·áÇÏ´Â ¹æ¹ýÀÌ´Ù. X¼±À̳ª ¶óµãÀÇ ¥ã¼± µîÀÇ ¹æ»ç¼±À» ¾ÏÁ¾À̳ª À°Á¾ µî¿¡ Á¶»çÇÏ¸é ¸Å¿ì À¯È¿ÇÏ´Ù´Â »ç½ÇÀº ±× ¹ß°ß Á÷ÈÄ¿¡ ÀÌ¹Ì ÀÎÁ¤µÇ¾úÀ¸³ª ½ÇÁ¦·Î ¾ÏÀ» Ä¡·áÇÏ¿© ³´°Ô ÇÑ »ç·ÊµéÀº 1920³â´ëºÎÅÍÀ̰í, ±× µ¿¾È ¿©·¯ °¡Áö·Î ¿¬±¸ º¸¿ÏµÇ¾î ¿À´Ã¿¡ À̸£°í ÀÖ´Ù. ¹æ»ç¼± ¿ä¹ýÀ¸·Î ÀÌ¿ëµÇ´Â °ÍÀº ÀÌ¿ÂÈ­ ¹æ»ç¼±À¸·Î, X¼±À̳ª ¥ã¼±°ú °°Àº ÀüÀÚ±âÆÄ¿Í ¥á¼±, ¥â¼±, Áß¼ºÀÚ¼±¤ý¾ç¼ºÀÚ¼±°ú °°Àº ÀÔÀÚ¼±ÀÌ´Ù. ÀÌµé ¹æ»ç¼±Àº »ýü¿¡ ´ëÇØ ÆÄ±« ÀÛ¿ëÀÌ ÀÖ°í, ¾î´À Á¤µµ ÀÌ»óÀ» ÇÇÆø½ÃŰ¸é ¼¼Æ÷°¡ »ç¸ê ºØ±«µÇ¾î ¹ö¸°´Ù. ±×¿Í °°Àº Á÷Á¢ÀûÀÎ ÆÄ±« ÀÛ¿ëÀ» ÀÌ¿ëÇÏ¿© ¾Ï µîÀÇ Á¶Á÷À» ¼¶¸ê½ÃÄÑ Ä¡·á ¸ñÀûÀ» ÀÌ·ç´Â °ÍÀ¸·Î, ¾ÏÁ¾À̳ª À°Á¾ À̿ܿ¡µµ Ç÷°üÁ¾À̳ª ÄÉ·ÎÀ̵å¿Í °°Àº ¾ç¼º Á¾¾çÀ» ºñ·ÔÇÏ¿© ¿©·¯ °¡Áö ÇǺκ´¿¡µµ ÀÀ¿ëµÈ´Ù. ¶ÇÇÑ °£Á¢Àû ÀÛ¿ë¿¡ ÀÇÇÑ °ÍÀ¸·Î´Â ½Å°æ¿¡ ÀÛ¿ëÇÏ¿© ±â´ÉÀû ¾ïÁ¦¸¦ ÃÊ·¡ÇÏ´Â °æ¿ì³ª ÆÄ±« ÀÛ¿ë¿¡ ÀÇÇØ »ý±ä ´Ü¹é ºÐÇØ »ê¹° µî¿¡ ÀÇÇÑ °£Á¢ÀûÀÎ ÀÚ±Ø ÀÛ¿ë¿¡ ÀÇÇÑ °Íµµ ÀÖ´Ù. °áÇÙÀ̳ª õ½Ä µî¿¡ ´ëÇÑ °ÍÀÌ ±× ´ëÇ¥ÀûÀÎ ¿¹·Î, È­ÇÐ ¿ä¹ý¸¸À¸·Î ³­Ä¡ÀÎ °æ¿ì¿¡ ¹Ì·®ÀÇ ¹æ»ç¼±À» Á¶»çÇϸé ȯºÎ¿¡ ºÐÇØ »ê¹°ÀÌ »ý±â°í, ±¹¼ÒÀûÀÎ ÀÚ±Ø ÀÛ¿ë¿¡ ÀÇÇØ ±Þ¼Óµµ·Î °üÇØµÈ´Ù. 1895³â ·ÛÆ®°ÕÀÇ X¼± ¹ß°ß°ú 98³â Äû¸®¿¡ ÀÇÇÑ ¶óµã ¹ß°ß ÀÌÈÄ ¹Ý¼¼±â µ¿¾È ±× Áß ¶óµãÀÌ ¹æ»ç¼± Ä¡·áÀÇ ÁÖ¿ªÀ» ¸Ã¾Æ ¿Ô´Ù. ÃÊâ±â¿¡´Â Ä¡·á¿¡ »ç¿ëµÇ´Â X¼± ¼±·®À» ¸ô¶ó °¢ÀÚÀÇ °æÇè¿¡ ÀÇÇØ ¹è·®ÇÏ¿´À¸¸ç, ¿¹±âÄ¡ ¸øÇÑ X¼± È­»óÀ» ¾ß±âÇÏ´Â Àϵµ ÀÖ¾ú´Ù. ½ÃÀÏÀÌ °æ°úÇÔ¿¡ µû¶ó ½Åü Ç¥¸éÀ¸·ÎºÎÅÍ ½ÉºÎ¿¡ À§Ä¡ÇÏ´Â Á¾¾ç¿¡ ´Ù·®ÀÇ X¼±À» µµ´Þ½Ã۱â À§ÇØ X¼± ¹ß»ý ÀåÄ¡ÀÇ °³·®ÀÌ ½ÃµµµÇ¾î 1920~30³â´ë´Â ºü¸¥ ¹ßÀüÀ» ÀÌ·èÇÏ¿´´Ù. ¶óµãÀº ½º½º·Î ¹æÃâÇÏ´Â ¥ã¼±ÀÇ °­µµ¿Í ¼±ÁúÀÌ ¿©·¯ ¾Ï ÁúȯÀ» Ä¡·áÇÏ´Â µ¥ ÀÌ»óÀûÀ̾ Áö³­ ¹Ý¼¼±â»Ó¸¸ ¾Æ´Ï¶ó ÇöÀçµµ ¾Ï Ä¡·á¿¡ Å« ¸òÀ» ´ã´çÇϰí ÀÖ´Ù. 1934³â P. Äû¸®, ·Î·»½º, Æä¸£¹Ì µîÀÌ °¢°¢ ¥á ÀÔÀÚ, Áß¼ºÀÚ, »çÀÌŬ·ÎÆ®·Ð µîÀ» ÀÌ¿ëÇÏ¿© óÀ½À¸·Î Àΰø ¹æ»ç¼º µ¿À§¿ø¼ÒÀÇ »ý»ê¿¡ ¼º°øÇÏ¿´°í, ÀÌ¾î Æä¸£¹Ì´Â 39³â ´º¿å¿¡ óÀ½À¸·Î ¿øÀڷθ¦ °Ç¼³ÇÔÀ¸·Î½á Á¦2Â÷´ëÀü ÈÄ ¿À´Ã³¯¿¡ º¸´Â °¢Á¾ Àΰø ¹æ»ç¼º µ¿À§¿ø¼Ò¸¦ ´ë·® »ý»êÇÒ ¼ö ÀÖ´Â ±æÀ» Åͳõ¾Ò´Ù. Áï, ¶óµã À̿ܿ¡µµ ´Ù·®ÀÇ ¥ã¼±À» ³¾ ¼ö ÀÖ´Â ¹°ÁúÀ» ´Ù°¢µµ·Î ¸ð»öÇÑ °á°ú¿´´Ù. À̵é Àΰø ¹æ»ç¼º µ¿À§¿ø¼Ò´Â X¼±°ú ¶óµãÀÇ ´ë¿ëÀº ¹°·Ð ³»¿ë µî ÀüÇô »õ·Î¿î ¾Ï Ä¡·áÀÇ ±æÀ» ¿­¾î ³õ¾ÒÀ¸¸ç, ±× ´ëÇ¥ÀûÀÎ ¿¹·Î¼­ ÄÚ¹ßÆ® 60 0CoÀ» ²ÅÀ» ¼ö ÀÖ´Ù. ÇöÀç ÀÌ¿ëµÇ°í ÀÖ´Â ¹æ»ç¼± ¿ä¹ý¿¡´Â ´ÙÀ½°ú °°Àº °ÍÀÌ ÀÖ´Ù. ¨ç X¼± ½ÉºÎ Ä¡·á : 20¸¸ V Á¤µµÀÇ X¼±Ä¡·á°¡ ÁÖÀ̸ç, Ç¥À缺ÀÎ Áúȯ¿¡´Â 3¸¸~7¸¸ VÀÇ ¿¬¼±µµ ÀÌ¿ëµÈ´Ù. ¨è ¶óµã ¿ä¹ý : ´ë°³´Â ¥ã ¼± ¿ä¹ýÀ¸·Î ¹é±Ý°ü ¶Ç´Â ħÀÌ »ç¿ëµÇ¸ç, ÀÚ±ÃÀ̳ª ºñ°­ °°Àº ºÎÀ§¿¡´Â ü°­ ³» Á¶»ç¿Í ¶óµã ħ¿¡ ÀÇÇÑ Á¶Á÷³» Á¶»çµµ À¯È¿ÇÏ´Ù. ¨é ÄÚ¹ßÆ® 60ÀÇ ´ë·® Á¶»ç : 0Co¿¡¼­ ¹æÃâµÇ´Â ¥ã¼±ÀÇ ³ôÀº Åõ°ú·ÂÀº ÇǺο¡ Å« ¼Õ»óÀ» ÁÖÁö ¾Ê°í ÃæºÐÇÑ ¾çÀÇ ¹æ»ç¼±À» Á¾¾ç¿¡ ÂÚ ¼ö ÀÖÀ¸¹Ç·Î, Á¾·¡ X¼± Ä¡·á¿¡¼­ º¸´ø ½ÉÇÑ È­»ó¿¡ µû¸¥ °íÅëÀ» ÁÖÁö ¾Ê°í Ä¡·á°¡ °¡´ÉÇÑ µ¿½Ã¿¡ ÀÏ·üÀûÀÎ ±ÕµîÇÑ Åõ°ú·ÂÀ» °¡Áø´Ù. µû¶ó¼­ X¼± Ä¡·á¿¡¼­ ÈçÈ÷ °æÇèÇÑ ¹Ù¿Í °°ÀÌ °ñ°Ý Á¶Á÷¿¡ ¿©ºÐÀ¸·Î Èí¼öµÇ¾î Ä¡·á ÈÄ X¼± °ú´Ù Èí¼ö·Î ÀÎÇØ ¿¹±âÄ¡ ¸øÇÑ º´Àû °ñÀýÀÇ ¿ì·Áµµ ¾ø°Ô µÇ¾ú´Ù. »Ó¸¸ ¾Æ´Ï¶ó 0CoÀ¸·ÎºÎÅÍ ¹æÃâµÇ´Â ¹æ»ç¼±·®Àº ¼Õ½±°Ô °è»êÇÒ ¼ö ÀÖÀ¸¹Ç·Î °ú¼Ò, °ú´Ù Á¶¸í µî ±â¼ú»ó Âø¿ÀÀÇ ¿ì·Á°¡ ¾øÀ¸¸ç, ½Ã¼³, ÀåÄ¡ µîÀÌ ¸Å¿ì °£ÆíÇÏ¿© ÁøÀÚ, ȸÀü Á¶»ç¹ý µî Ä¡·á ±â¼úÀ» ÀÚÀ¯ÀÚÀç·Î ¹ßÈÖÇÒ ¼ö ÀÖ´Ù. Çѱ¹¿¡ 0CoÀÌ Ã³À½ µµÀÔ, °¡µ¿µÈ °ÍÀº 1963³â Çö ¿øÀڷº´¿ø¿¡ ÀÖ´Â 3,000 Ci ¿ë·®ÀÇ °ÍÀÌ´Ù. ÇÑÆí, º¸´Ù °­·ÂÇÑ X¼±À» »©³» ¾²±â À§ÇØ ¼³°èµÈ °ÍÀÌ ¼±Çü °¡¼Ó ÀåÄ¡·Î¼­ ¼º´É¸é¿¡¼­ º¸´Ù °³¼±µÈ °ÍÀÌ ¸¶ÀÌÅ©·ÎÆ®·ÐÀÌ´Ù. ¨ê Ãʰí¾Ð ¹æ»ç¼± ¿ä¹ý : 400¸¸~800¸¸ VÀÇ X¼±À» ³»´Â ¼±Çü °¡¼ÓÀåÄ¡
  • absolute field
    Àý´ë ºÎ
    ´ë³úÀÇ ÀϺηÎ, ±× º´º¯¿¡ ÀÇÇØ °æ·Ã ¶Ç´Â ¸¶ºñ¸¦ ÀÏÀ¸Å²´Ù.
  • abutted field
    ÀÎÁ¢ Á¶»ç¸é
  • bright field photomicrograph
    ?
  • color field
    »ö ½Ã¾ß
  • constant field equation
    Á¤ÀüÀå ¹æÁ¤½Ä
  • cortical field
    ÇÇÁú ¿µ¿ª
  • dark-field microscope
    ¾Ï½Ã¾ß Çö¹Ì°æ
    ¾Ï½Ã¾ß Á¶¸í¹ý¿¡ ÀÇÇØ º¸ÅëÀÇ Çö¹Ì°æÀ¸·Î´Â º¸ÀÌÁö ¾Ê´Â ¹Ì¼¼ÇÑ ÀÔÀÚ¸¦ º¼ ¼ö ÀÖ´Â Çö¹Ì°æ. ÇÑ¿Ü Çö¹Ì°æÀ» ¸»Çϴµ¥, ¾Ï½Ã¾ß Á¶¸í°ú ±× Áý±¤ ·»Á »ç¿ëÇϹǷΠÀÌ¿Í °°ÀÌ ºÒ¸®±âµµ ÇÑ´Ù.
  • depository field
    ÷°¡ ¾ß
  • electromagnetic field
    ÀüÀÚÀå
    1. Àü±âÀå°ú ÀÚ±âÀåÀ» ÅëÆ²¾î ÁöĪÇÏ´Â ¸». 2. Àü±âÀå°ú ÀÚ±âÀåÀÌ ¼­·Î ¿¬°üµÇ¾î °°ÀÌ ³ªÅ¸³¯ ¶§ À̸£´Â ¸».
  • equivalent field
    µî°¡ Á¶»ç ¿µ¿ª
  • eye field
    ½Ã¾ß
  • far field
    ¿ø°Å¸® ±¸¿ª
  • field
    ±¸¿ª, ¾ß, ¿µ¿ª
    1. ÀÛ¿ë ¿µ¿ª ¶Ç´Â Àå¼Ò³ª °ø°£. 2. Áö½Ä, ¿¬±¸, Á÷¾÷¿¡ À־ÀÇ Àü¹® ºÐ¾ß. 3. ¹ß»ýÇп¡ ÀÖ¾î º¯µ¿ ¿äÀÎÀÇ ¹üÀ§ ³»¿¡¼­ ºÐÈ­ÇÏ´Â ¿µ¿ª.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
involved <zoology> Same as Involute.
Source: Websters Dictionary
(01 Mar 1998)
radiotherapy <oncology> The treatment of disease by ionising radiation.
Origin: Gr. Therapeia = cure
(18 Nov 1997)
radiotherapy, adjuvant Radiotherapy given to augment some other form of treatment such as surgery or chemotherapy. Adjuvant radiotherapy is commonly used in the therapy of cancer and can be administered before or after the primary treatment.
(12 Dec 1998)
radiotherapy, computer-assisted Computer systems or programs used in accurate computations for providing radiation dosage treatment to patients.
(12 Dec 1998)
radiotherapy dosage The total amount of radiation absorbed by tissues as a result of radiotherapy.
(12 Dec 1998)
radiotherapy, high-energy Radiotherapy using high-energy (megavolt or higher) ionizing radiation. Types of radiation include gamma rays, produced by a radioisotope within a teletherapy unit; X-rays, electrons, protons, alpha particles (helium ions) and heavy charged ions, produced by particle acceleration; and neutrons and pi-mesons (pions), produced as secondary particles following bombardment of a target with a primary particle.
(12 Dec 1998)
radiotherapy localization Planning the size and alignment of radiation beams to encompass the neoplasm to be treated.
(05 Mar 2000)
radiotherapy planning, computer-assisted Computer-assisted mathematical calculations of beam angles, intensities of radiation, and duration of irradiation in radiotherapy.
(12 Dec 1998)
auditory field The space included within the limits of hearing of a definite sound, as of a tuning fork.
(05 Mar 2000)
bright field illumination <microscopy> The method of lighting the specimen with a solid cone of rays. Transmitted bright field illumination is performed by a substage condenser. Reflected bright field illumination is performed by a vertical illuminator.
Compare: dark field illumination
(05 Aug 1998)
bright field imaging <microscopy> An imaging mode in a transmission electron microscopy that uses only unscattered Electrons to form the image. Contrast in such an image is due entirely to mass-thickness variations in amorphous samples, and may include diffraction contrast in crystalline samples.
(05 Aug 1998)
bright field microscopy <technique> Optical microscopy, in which absorption to a great extent and diffraction to a minor extent give rise to the image, as opposed to phase contrast or interference methods of microscopy.
(18 Nov 1997)
Broca's field The posterior part of the inferior frontal gyrus of the left or dominant hemisphere, corresponding approximately to Brodmann's area 44; Broca identified this region as an essential component of the motor mechanisms governing articulated speech.
Synonym: Broca's area, Broca's field, motor speech centre.
(05 Mar 2000)
cardioid dark field condenser <microscopy> A condenser designed with two reflecting surfaces, the first, a spherical surface which reflects the rays to a second, cardioid (heart-shaped) surface. The virtue in such an arrangement is that, if the cardioid surface is of true figure, the lens is both achromatic and aplanatic. It has a limiting numerical aperture of about 1.0. Thus objectives of a greater numerical aperture cannot be used successfully with it. A true cardioid figure is the trace of a point on the circumference of a circle rolling around an equal, fixed circle.
(05 Aug 1998)
magnetic field The sphere of influence of a magnet.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • involved
    ¸»¾Æ ³ÖÀº
  • radiotherapy
    ¹æ»ç¼± Ä¡·á¹ý
  • involved
    º¹ÀâÇÑ;µÚ¾ôÈù;È¥¶õÇÑ;(°æÁ¦ÀûÀ¸·Î)°ï¶õÇÑ;(»ç°Çµî¿¡)±íÀÌ °ü·ÃµÈ;¸»·Áµç;¿­ÁßÇÏ¿©
  • radiotherapy
    ¹æ»ç¼± ¿ä¹ý;¹æ»ç¼± Ä¡·á»çÀÇ ÀÏ;-pist ¹æ»ç¼± Ä¡·á»ç
  • field
    ÀüÅõ,ÅõÁö,½Î¿ì´Ù,´ÙÅõ´Ù
  • Field Marshal
    À°±º ¿ø¼ö
  • Field prize
    Çʵå»ó
  • brick field
    º®µ¹°øÀå
  • center field
    ¼¾ÅÍ(ÀÇ ¼öºñÀ§Ä¡)
  • dark field
    (Çö¹Ì°æÀÇ) ¾Ï½Ã¾ß
  • dark field illumination
    ¾Ï½Ã¾ß Á¶¸í¹ý(Çö¹Ì°æ ½Ã·áÀÇ)
  • dark field microscope
    (±¤)ÇÑ¿Ü Çö¹Ì°æ;¾Ï½Ã¾ß Çö¹Ì°æ
  • electric field
    Àü°è
  • field
    µé;¹úÆÇ;¹ç;±¤Àå;Ç¥¸é;»êÁö;½Î¿òÅÍ;°æ±âÀå;³»(¿Ü)¾ß;ºÐ¾ß;¹ÙÅÁ;¿µ»ó¸é(coal field źÀü)
  • field allowance
    ÃâÁ¤ ¼ö´ç
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á